Register entry

TRIPOINT THERAPEUTICS, LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
6
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: NDA 2, ANDA 1.

Dosage formNDCs
tablet, extended release2
tablet1
RouteNDCs
oral3
Labeller name on the listingNDCs
tripoint therapeutics, llc3
Exclusivity

Patents and exclusivities

6
PatentProductCoversExpiry
8163306ELEPSIA XRlevetiracetamproductSept 2027
8431156ELEPSIA XRlevetiracetamproductOct 2027
8470367ELEPSIA XRlevetiracetamproductOct 2027
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
Carbinoxamine MaleateCarbinoxamine Maleatetablet, oral80705-120ANDA
ELEPSIA XR 1000 MGlevetiracetamtablet, extended release, oral80705-100NDA
ELEPSIA XR 1500 MGlevetiracetamtablet, extended release, oral80705-101NDA
Compare

Other companies listing levetiracetam

Enquiry

Common questions

Is TRIPOINT THERAPEUTICS, LLC FDA approved?
TRIPOINT THERAPEUTICS, LLC holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does TRIPOINT THERAPEUTICS, LLC make?
3 products are listed under TRIPOINT THERAPEUTICS, LLC in the openFDA NDC Directory, most often as tablet, extended release; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.